427 related articles for article (PubMed ID: 36414227)
1. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.
Jakubek YA; Reiner AP; Honigberg MC
Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227
[TBL] [Abstract][Full Text] [Related]
2. Determinants of mosaic chromosomal alteration fitness.
Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJF; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun JH; DeMeo D; Levy D; Johnson AD; Mathias RA; Taub MA; Arnett D; North KE; Raffield LM; Carson AP; Doyle MF; Rich SS; Rotter JI; Guo X; Cox NJ; Roden DM; Franceschini N; Desai P; Reiner AP; Auer PL; Scheet PA; Jaiswal S; Weinstock JS; Bick AG
Nat Commun; 2024 May; 15(1):3800. PubMed ID: 38714703
[TBL] [Abstract][Full Text] [Related]
3. Genetics of smoking and risk of clonal hematopoiesis.
Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P
Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625
[TBL] [Abstract][Full Text] [Related]
4. Clonal hematopoiesis, somatic mosaicism, and age-associated disease.
Evans MA; Walsh K
Physiol Rev; 2023 Jan; 103(1):649-716. PubMed ID: 36049115
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis Analyses in Clinical, Epidemiologic, and Genetic Aging Studies to Unravel Underlying Mechanisms of Age-Related Dysfunction in Humans.
Walsh K; Raghavachari N; Kerr C; Bick AG; Cummings SR; Druley T; Dunbar CE; Genovese G; Goodell MA; Jaiswal S; Maciejewski J; Natarajan P; Shindyapina AV; Shuldiner AR; Van Den Akker EB; Vijg J
Front Aging; 2022; 3():841796. PubMed ID: 35821803
[TBL] [Abstract][Full Text] [Related]
6. Clonal hematopoiesis due to mosaic chromosomal alterations: Impact on disease risk and mortality.
Hubbard AK; Brown DW; Machiela MJ
Leuk Res; 2023 Mar; 126():107022. PubMed ID: 36706615
[TBL] [Abstract][Full Text] [Related]
7. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
8. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
Marnell CS; Bick A; Natarajan P
J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
[TBL] [Abstract][Full Text] [Related]
11. Clonal hematopoiesis of indeterminate potential and cardiovascular disease.
Saadatagah S; Ballantyne CM
Transl Res; 2023 May; 255():152-158. PubMed ID: 36067904
[TBL] [Abstract][Full Text] [Related]
12. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
13. [Importance of clonal hematopoiesis for hematologic neoplasms].
Götze KS; Lengerke C
Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
[TBL] [Abstract][Full Text] [Related]
14. Association of the interaction between mosaic chromosomal alterations and polygenic risk score with the risk of lung cancer: an array-based case-control association and prospective cohort study.
Qin N; Wang C; Chen C; Yang L; Liu S; Xiang J; Xie Y; Liang S; Zhou J; Xu X; Zhao X; Zhu M; Jin G; Ma H; Dai J; Hu Z; Shen H
Lancet Oncol; 2022 Nov; 23(11):1465-1474. PubMed ID: 36265503
[TBL] [Abstract][Full Text] [Related]
15. Serum biomarkers are altered in UK Biobank participants with mosaic chromosomal alterations.
Hubbard AK; Brown DW; Zhou W; Lin SH; Genovese G; Chanock SJ; Machiela MJ
Hum Mol Genet; 2023 Nov; 32(22):3146-3152. PubMed ID: 37565819
[TBL] [Abstract][Full Text] [Related]
16. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
17. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
18. Determinants of mosaic chromosomal alteration fitness.
Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJ; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun J; DeMeo D; Levy D; Johnson A; Mathias R; Taub M; Arnett D; North K; Raffield LM; Carson A; Doyle MF; Rich SS; Rotter JI; Guo X; Cox N; Roden DM; Franceschini N; Desai P; Reiner A; Auer PL; Scheet P; Jaiswal S; Weinstock JS; Bick AG
medRxiv; 2023 Oct; ():. PubMed ID: 37905118
[TBL] [Abstract][Full Text] [Related]
19. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
Goldman EA; Spellman PT; Agarwal A
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
